Prepare an internal analytics purchase brief that names the business decision, budget owner, current process, proposed scope, costs and evidence needed for approval.
An analytics purchase becomes reviewable when it has a specific decision, a budget owner and an evidence-based scope. Explain the current reporting problem, what the proposed purchase changes and which uncertainties remain. Separate cash spending from assigned employee time. Ask for an identifiable commitment, with a reviewer and a decision date, instead of asking someone to approve “better insights.”
This guide owns the internal approval brief. The account-growth business case separately covers contribution break-even and attribution for a particular review.
Describe the action that the reporting will inform. “Select ten accounts for an expansion review” is easier to assess than “use AI across sales.” Name who makes the decision, when it is made and which data currently informs it.
Explain the failure in the current process without exaggeration. Perhaps account identities are reconciled manually, a review starts too late, or the manager cannot inspect the source behind a total. Record a recent representative cycle and its limitations. Do not assume a new dashboard fixes issues that originate in unavailable or ambiguous data.
Identify the alternative if no purchase is made. Approval is a choice between feasible options, including continuing the current process or using an existing tool.
The business owner is responsible for using the output. The budget owner authorizes spending. A data owner supplies authorized records and clarifies their meaning. Finance may review arithmetic and revenue basis, while a technical or procurement reviewer evaluates relevant service requirements.
State the unresolved questions each person must answer. A sponsor's enthusiasm does not substitute for a data owner's permission or a finance review. Equally, a technical checklist should not hide the absence of a business user who intends to use the result.
Keep the approval request small enough that each responsibility is clear. Wider deployment can require a separate decision after the initial evidence is available.
DEMO-APPROVAL-01 is an invented purchase brief, not a Covirage quotation. An initial engagement costs $2,000. Preparation takes twelve internal hours and review takes eight, valued at an illustrative $50 per hour.
| Budget component | Calculation | Amount |
|---|---|---|
| Supplier fee | Proposed bounded scope | $2,000 |
| Preparation effort | 12 × $50 | $600 |
| Review effort | 8 × $50 | $400 |
| Combined evaluation cost | $2,000 + $600 + $400 | $3,000 |
The immediate supplier payment is $2,000. The additional $1,000 is an assigned value for internal capacity, not automatically additional payroll cash. State both so the approver can evaluate budget and workload separately.
Suppose the existing monthly process takes twenty hours and the proposed process is estimated to take eight. The scenario releases twelve hours per month, or 144 over twelve months. At $50 per hour, that is $7,200 of assigned capacity. It remains a scenario until measured; it is not proven cash savings or a forecast of sales growth.
Attach one relevant output example, source description and list of acceptance questions. Label demonstrations as demonstrations and synthetic figures as synthetic. A demo, trial or pilot should answer the particular uncertainty being funded.
For DEMO-APPROVAL-01, approval might depend on reconciling a sample to an agreed total and having the manager inspect the account list without assistance. Shared access, recovery or recurring delivery could remain excluded and require separate evidence before a wider commitment.
Record what would cause the proposal to stop or change. A missing customer identifier or unavailable denominator can justify narrowing the question rather than extending the project indefinitely.
State the maximum initial commitment, included deliverables, evaluation period and named reviewer. Explain whether the request is for a one-off engagement or recurring access; the purchase-duration guide covers that distinction.
Specify who approves additional scope and how unresolved dependencies will be returned to the sponsor. Avoid an approval brief that lists a modest initial fee but quietly assumes a much larger later implementation. Future benefits and future costs should remain visible together.
Use the synthetic customer-growth report example to describe the result your business owner wants. Then contact Covirage with the decision, available inputs and approval constraints. Agree a reviewable scope and the evidence your budget owner needs.
Name the person accountable for the business decision and the person authorized to approve its budget. They may be different, and technical and data reviewers can have separate responsibilities.
Not automatically. Distinguish released capacity from an actual reduction in incremental payments, and explain how the released time would be used.
Only if that scope is justified and specified. A bounded decision can provide clearer evidence than an undefined organization-wide promise.